中汽協:9月新能源汽車市場表現依然出色,產銷量再上新臺階
格隆匯10月14日丨中汽協:2021年9月,新能源汽車產銷分別達到35.3萬輛和35.7萬輛,環比增長14.5%和11.4%,同比增長均爲1.5倍。1-9月,新能源汽車產銷分別達到216.6萬輛和215.7萬輛,同比增長1.8倍和1.9倍。9月,在新能源汽車主要品種中,與上月相比,純電動和插電式混合動力汽車產銷均呈增長;與上年同期相比,純電動和插電式混合動力汽車產銷同樣保持迅猛增長。1-9月,在新能源汽車主要品種中,與上年同期相比,純電動和插電式混合動力汽車產銷均延續了高速增長勢頭。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.